PALA, LAURA
 Distribuzione geografica
Continente #
NA - Nord America 2.818
EU - Europa 1.835
AS - Asia 407
AF - Africa 6
Continente sconosciuto - Info sul continente non disponibili 1
OC - Oceania 1
Totale 5.068
Nazione #
US - Stati Uniti d'America 2.816
RU - Federazione Russa 650
PL - Polonia 560
IE - Irlanda 193
IT - Italia 148
SE - Svezia 148
SG - Singapore 119
HK - Hong Kong 93
CN - Cina 85
JO - Giordania 44
FI - Finlandia 43
DE - Germania 30
IN - India 28
CH - Svizzera 16
VN - Vietnam 15
GB - Regno Unito 14
UA - Ucraina 13
BE - Belgio 7
FR - Francia 7
TR - Turchia 7
CI - Costa d'Avorio 5
IR - Iran 3
KR - Corea 3
AE - Emirati Arabi Uniti 2
CA - Canada 2
ES - Italia 2
MM - Myanmar 2
MY - Malesia 2
NL - Olanda 2
EU - Europa 1
IL - Israele 1
LV - Lettonia 1
MA - Marocco 1
NZ - Nuova Zelanda 1
PT - Portogallo 1
TH - Thailandia 1
TW - Taiwan 1
UZ - Uzbekistan 1
Totale 5.068
Città #
Santa Clara 792
Warsaw 560
Fairfield 291
Chandler 212
Dublin 193
Ashburn 166
Seattle 141
Woodbridge 135
Cambridge 128
Wilmington 108
Singapore 106
Houston 95
Ann Arbor 70
Hong Kong 51
Altamura 48
Princeton 48
Lawrence 47
Buffalo 41
Boston 28
Beijing 27
Jacksonville 27
Florence 24
San Diego 23
Mumbai 22
Kent 21
Moscow 21
Medford 19
Shanghai 18
Rome 16
Bern 15
Los Angeles 15
Dong Ket 14
Boardman 13
Helsinki 11
Falls Church 8
New York 8
Brussels 7
Norwalk 7
Andover 6
Izmir 6
Abidjan 5
Falkenstein 4
Frankfurt am Main 4
Hillsboro 4
London 4
Milan 4
Munich 4
Phoenix 4
West Jordan 4
Dearborn 3
Guangzhou 3
Pune 3
Selvazzano Dentro 3
Seoul 3
Barcelona 2
Campi Bisenzio 2
Catania 2
Chennai 2
Cotignola 2
Dubai 2
Kilburn 2
Marcallo con Casone 2
Naples 2
Shah Alam 2
Siena 2
Toronto 2
Yangon 2
Amsterdam 1
Auburn Hills 1
Auckland 1
Bolzano 1
Campagnano Di Roma 1
Centrale 1
Changsha 1
Columbus 1
Dalmine 1
Essen 1
Frankfurt Am Main 1
Haifa 1
Haining 1
Hengyang 1
Incisa 1
Kaili 1
Ladispoli 1
Lappeenranta 1
Leawood 1
Mcallen 1
Nanjing 1
Nanyang 1
Nocera Superiore 1
Pak Kret 1
Pavia 1
Redmond 1
Redwood City 1
Reggio Calabria 1
Riga 1
San Mateo 1
Santo Tirso 1
Shenzhen 1
Shijiazhuang 1
Totale 3.699
Nome #
Fit and motivated: outcome predictors in patients starting a program for lifestyle change. 249
The role of DPP4 activity in cardiovascular districts: in vivo and in vitro evidence. 231
Inflammatory molecules affect the interaction between human dendritic cells and vascular smooth muscle cells 207
The therapy of insulin resistance in other diseases besides type 2 diabetes. 187
False and true pre-treatment predictors of weight loss in obese patients starting a program for lifestyle change. 184
Lower and higher-potency statins on glycemic control in type 2 diabetes: A retrospective cohort study 153
Different modulation of dipeptidyl peptidase-4 activity between microvascular and macrovascular human endothelial cells. 152
Characterization of circulating and monocyte-derived dendritic cells in obese and diabetic patients 150
Relationship between GLP-1 levels and dipeptidyl peptidase-4 activity in different glucose tolerance conditions. 141
Effects of glucagon-like peptide-1 receptor agonists on mortality and cardiovascular events: A comprehensive meta-analysis of randomized controlled trials 135
Dipeptidyl peptidase-IV expression and activity in human glomerular endothelial cells 126
Dendritic cell phenotype and function are modulated by inflammation and insulin-resistance. 120
Diabetic microangiopathy: IGFBP control endothelial cell growth by a common mechanism in spite of their species specificity and tissue peculiarity. 118
Adjustment of insulin doses when switching from glargine 100 U/ml or detemir to degludec: an observational study 118
Failure to metformin and insulin secretagogue monotherapy: an observational cohort study. 115
Glucagon-like peptide-1 response to meals and post-prandial hyperglycemia in Type 2 diabetic patients. 112
A comparison of mealtime insulin aspart and human insulin in combination with metformin in type 2 diabetes patients 111
Bone fractures and hypoglycemic treatment in type 2 diabetic patients: a case-control study. 110
Continuous subcutaneous insulin infusion vs modern multiple injection regimens in type 1 diabetes: an updated meta-analysis of randomized clinical trials 109
Insulin resistance and obesity affect monocyte-derived dendritic cell phenotype and function 109
Glomerular hyperfiltration and metabolic syndrome: results from the FIrenze-BAgno A Ripoli (FIBAR) Study 108
Treatment with insulin secretagogues and cancer-related mortality in type 2 diabetic patients a retrospective cohort study. 107
Clinical approach to diabetic cardiomyopathy: A review of human studies 107
Liver enzymes and risk of diabetes and cardiovascular disease: results of the Firenze Bagno a Ripoli (FIBAR) study. 102
Motivational enhancement therapy in obese patients: A promising application 99
Time to insulin in type-2 diabetes: high hurdles or Santiago way? 95
Meccanismi infiammatori regolano le interazioni tra cellule muscolari coronariche lisce e cellule dendritiche umane 92
Studio del fenotipo delle cellule dendritiche di pazienti obesi ed insulino resistenti e della loro interazione con cellule muscolari lisce coronariche umane. 92
Doses of insulin and its analogues and cancer occurence in insulin-treated type 2 diabetic patients. 88
Long-term interactive group education for type 1 diabetic patients 88
National Cholesterol Education Program and International Diabetes Federation definitions of metabolic syndrome in the prediction of diabetes. Results from the FIrenze-Bagno A Ripoli study. 87
Assessment of left ventricular global longitudinal strain in patients with type 2 diabetes: Relationship with microvascular damage and glycemic control 84
Patient-Reported Outcomes of COVID-19 Vaccine Breakthrough Infection-Associated Changes in Glucose Control in Subjects With Type 1 Diabetes (PRO-VACS 2 Study) 82
Periodontitis predicts HbA1c levels and glucose variability in type 1 diabetic patients: the PARODIA Florence Project study 81
Effects of real-time continuous glucose monitoring in type 1 diabetes: a meta-analysis of randomized controlled trials 80
Role of insulin in the type 2 diabetes therapy: past, present and future. 77
Glucose variability and periodontal disease in type 1 diabetes: a cross-sectional study-The "PAROdontopatia e DIAbete" (PARODIA) project 76
Body mass index (BMI), waist circumference (WC), waist-to-height ratio (WHtR) e waist body mass index (wBMI): Which is better? 76
Online group lifestyle modification programs for obesity during the COVID-19 pandemic: The EDucation ONline (EDON) retrospective study 76
Interstitial glucose monitoring, type 1 diabetes and COVID-19 vaccine: the patient-reported outcomes and vaccine-associated changes in glucose and side effects (PRO-VACS) 76
MANAGEMENT OF HYPERGLICEMIA IN TYPE 2 DIABETES: A CONSENSUS ALGORITHM FOR THE INITIATION AND ADJUSTMENT OF THERAPY: A CONSENSUS STATEMENT FROM THE AMERICAN DIABETES ASSOCIATION AND THE EUROPEAN ASSOCIATION FOR THE STUDY OF DIABETES 72
Glucose variability and periodontal disease in type 1 diabetes: a cross-sectional study—The “PAROdontopatia e DIAbete” (PARODIA) project 70
Characterization of dendritic cells in obese and diabetic patients 69
Orthorexia nervosa and type 1 diabetes: results of a cross-sectional study 63
Obesity therapy: How and why? 58
The "slower" the better 46
Correction to: Orthorexia nervosa and type 1 diabetes: results of a cross‑sectional study (Acta Diabetologica, (2023), 60, 5, (681-686), 10.1007/s00592-023-02044-9) 8
Glucagon-like peptide 1 (GLP1) receptor agonists and risk for ischemic optic neuropathy: A meta-analysis of randomised controlled trials 5
Totale 5.101
Categoria #
all - tutte 13.784
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 13.784


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020452 0 0 0 0 0 82 85 90 78 59 48 10
2020/2021374 39 34 17 33 17 32 24 28 46 51 22 31
2021/2022282 9 7 23 5 11 18 6 16 17 25 56 89
2022/2023889 74 178 38 76 46 152 110 42 122 4 20 27
2023/2024320 17 33 49 17 14 53 19 62 7 17 26 6
2024/20251.808 85 238 147 374 640 324 0 0 0 0 0 0
Totale 5.101